The Anaortic Technique with Bilateral Internal Thoracic Artery Grafting - Filling the Gap in Coronary Artery Bypass

Walter J Gomes1, Eduardo N Gomes2, Ayrton Bertini2

  • 1Cardiovascular Surgery Discipline, Hospital São Paulo, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

Insights

Anaortic off-pump coronary artery bypass grafting (anOPCAB) significantly reduces stroke risk in high-risk patients by avoiding aortic manipulation. This technique refines outcomes for patients with cerebrovascular disease or aortic calcification.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Vascular Medicine

Background:

  • Coronary artery bypass grafting (CABG) is effective for advanced coronary artery disease but carries a stroke risk.
  • Aortic manipulation during conventional CABG and cardiopulmonary bypass are linked to perioperative stroke.
  • Off-pump CABG (OPCAB) reduces some risks, but ascending aorta clamping for anastomosis remains a concern.

Purpose of the Study:

  • To evaluate the efficacy of anaortic off-pump CABG (anOPCAB) in mitigating stroke risk.
  • To compare anOPCAB with conventional CABG and standard OPCAB in high-risk patient populations.
  • To establish anOPCAB as a preferred technique for specific patient groups.

Main Methods:

  • Review of studies comparing anOPCAB with conventional CABG and OPCAB.
  • Analysis of perioperative stroke rates in patients undergoing different CABG techniques.
  • Focus on patient cohorts with cerebrovascular disease, aortic calcification, or atheromatous plaque.

Main Results:

  • Anaortic (aorta no-touch) OPCAB (anOPCAB) virtually eliminates embolism risk from aortic debris.
  • anOPCAB demonstrates a further decrease in postoperative stroke risk compared to standard OPCAB.
  • This technique is particularly beneficial for higher-risk patients, including those with cerebrovascular disease.

Conclusions:

  • anOPCAB represents a significant refinement of OPCAB, enhancing patient outcomes.
  • The technique is recommended for patients with cerebrovascular disease or aortic pathology.
  • anOPCAB should be preferred in patients with high risk factors for neurological damage and stroke.

Related Concept Videos